Sinai Health
Help Fuel NF1 Research at Sinai Health

Help Fuel NF1 Research at Sinai Health

When Craig and Claire Rankine’s son, Jonathan, was just eight months old he was diagnosed with the rare disease neurofibromatosis type1 (NF1). NF1 causes tumours to grow on the nervous system and can impact different parts of the body. In young children, NF1 typically appears as flat café au laitcoloured patches on the skin, which is how Jonathan’s condition was first detected.

Disappointed to learn the NF1 gene is rarely studied, the Rankine family were inspired to support research at Sinai Health’s Lunenfeld-Tanenbaum Research Institute (LTRI), one of the top global academic institutions in molecular and cell biology.

One way to address this need is to train the next generation of researchers to better understand the NF1 gene and its related complications. Your gifts will support a Research Fellowship allowing the LTRI to attract the best and brightest young scientists to train with leading Principal Investigators, and helping to build a critical mass of knowledge and expertise related to NF1.

Thank you for helping drive advances to alleviate the uncertainty experienced by NF1 patients and their families.